Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol versus calcitriol in peritoneal dialysis patients
NL-OMON37926Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of paricalcitol and calcitriol in chronic kidney disease (CKD) and secondary hyperparathyroidism (SHPT) (2 arms), sponsored by Vrije University Medical Center. Primary endpoints: Difference in markers of inflammation and Difference in peritoneal transport markers. Started May 2011; status: active, not recruiting.
02
Drugs
paricalcitolcalcitriol
03
Conditions
chronic kidney disease (CKD)secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NL-OMON37926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37926.